Hosted on MSN40m
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid VolatilityTonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...
TD Cowen reiterated its Buy rating and $20.00 price target for EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT). This aligns with the broader analyst consensus, as InvestingPro data shows analyst targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback